Silicone elastomer uptake method for determination of free 1-alkyl-2-pyrrolidone concentration in micelle and hydroxypropyl-β- cyclodextrin systems used in skin transport studies

Journal of Pharmaceutical Sciences

Volumn 97, Issue 1, 2008, Pages 368-380

  Warner, Kevin S ^a,b   Shaker, Dalia S ^b   Molokhia, Sarah ^b   Xu, Qingfang ^c   Hao, Jinsong ^c   Higuchi, William I ^b   Li, S Kevin ^b,c  

^a ZARS Pharma   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Absorption enhancer; Passive diffusion transport; Permeation enhancers; Skin; Transdermal

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2 PYRROLIDONE DERIVATIVE; CORTICOSTERONE; ELASTOMER; SILICONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; FEMALE; HYDROPHOBICITY; MICELLE; MOUSE; NONHUMAN; SKIN PERMEABILITY; SOLUBILIZATION;

EID: 38349126394     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21094     Document Type: Article

References (29)

1. Walters K, Hadgraft J, editors. 1993. Pharmaceutical skin penetration enhancers. New York: Marcel Dekker.
2. Phillips CA, Michniak BB. 1995. Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers. J Pharm Sci 84:1427-1433.
3. Okamoto H, Hashida M, Sezaki H. 1991. Effect of 1-alkyl- or 1-alkenylazacycloalkanone derivatives on the penetration of drugs with different lipophilicities through guinea pig skin. J Pharm Sci 80:39-45.
4. Mitragotri S. 2001. Effect of bilayer distruption on transdermal transport of low-molecular weight hydrophobic solutes. Pharm Res 18:1018-1023.
5. Kanikkannan N, Kandimalla K, Lamba SS, Singh M. 2000. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 7:593-608.
6. Potts R, Guy R, editors. 1997. Mechanisms of transdermal drug delivery. New York: Marcel Dekker.
7. Smith E, Maibach H, editors. 1995. Percutaneous penetration enhancers. Boca Raton: CRC Press.
8. He N, Warner KS, Chantasart D, Shaker DS, Higuchi WI, Kevin Li S. 2004. Mechanistic study of chemical skin permeation enhancers with different polar and lipophilic functional groups. J Pharm Sci 93:1415-1430.
9. Chantasart D, Li SK, He N, Warner KS, Prakongpan S, Higuchi WI. 2004. Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J Pharm Sci 93:762-779.
10. Warner KS, Li SK, Higuchi WI. 2001. Influences of alkyl group chain length and polar head group on chemical skin permeation enhancement. J Pharm Sci 90:1143-1153.
11. Warner KS, Li SK, He N, Suhonen TM, Chantasart D, Bolikal D, Higuchi WI. 2003. Structure-activity relationship for chemical skin permeation enhancers: probing the chemical microenvironment of the site of action. J Pharm Sci 92:1305-1322.
12. He N, Li SK, Suhonen TM, Warner KS, Higuchi WI. 2003. Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin. J Pharm Sci 92:297-310.
13. Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK. 1995. Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci 84:312-317.
14. Yoneto K, Li SK, Higuchi WI, Shimabayashi S. 1998. Influence of the permeation enhancers 1-alkyl-2-pyrrolidones on permeant partitioning into the stratum corneum. J Pharm Sci 87:209-214.
15. Stella VJ, Rajewski RA. 1997. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res 14:556-567.
16. Rajewski RA, Stella VJ. 1996. Pharmaceutical appUcations of cyclodextrins. 2. In vivo drug deUvery. J Pharm Sci 85:1142-1169.
17. Loftsson T, Brewster ME. 1996. Pharmaceutical applications of cyclodextrins. 1 Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.
18. Shaker DS, Ghanem AH, Li SK, Warner KS, Hashem FM, Higuchi WI. 2003. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin. Int J Pharm 253:1-11.
19. Ghanem AH, Mahmoud H, Higuchi WI, Rohr U, Borsadia S, Liu P, Fox JL, Good WR. 1987. The effects of ethanol on the transport of estradiol and other permeants in hairless mouse skin II. A new quantitative approach. J Cont Rel 6:75-83.
20. Ghanem AH, Mahmoud H, Higuchi WI, P L, R GW. 1992. The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: Methods/validation of a model approach. Int J Pharm 78:137-156.
21. Kim YH, Ghanem AH, Higuchi WI. 1992. Model studies of epidermal permeability. Semin Dermatol 11:145-156.
22. Kim YH, Ghanem A-H, Mahmoud H, Higuchi WI. 1995. Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: Mechanism(s) of action. Int J Pharm 80:17-31.
23. Sangster J. 1989. Octanol-water partition coefficients of simple organic compounds. J Phys Ref Data 18:1111-1228.
24. Verbruggen EMJ, Hermens JLM, Tolls J. 2001. Physicochemical properties of higher nonaromatic hydrocarbons: A literature study. J Phys Chem Ref Data 29:1435-1446.
25. Aungst BJ. 1989. Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants. Pharm Res 6:244-247.
26. Golden GM, McKie JE, Potts RO. 1987. Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci 76:25-28.
27. Tanojo H, Bouwstra JA, Junginger HE, Bodde HE. 1997. In vitro human skin barrier modulation by fatty acids: Skin permeation and thermal analysis studies. Pharm Res 14:42-49.
28. Leo A, Hansch C, Elkins D. 1971. Partition coefficients and their uses. Chem Rev 71:525-616.
29. Anderson BD, Raykar PV. 1989. Solute structure-permeability relationships in human stratum corneum. J Invest Dermatol 93:280-286.